 LogicBio Therapeutics, Inc. Nasdaq: LOGC LogicBio or the Company, a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced that its 2020 Annual Meeting of Stockholders 2020 Annual Meeting will be held in a virtual-only format due to continued public health concerns related to coronavirus COVID-19, and to support the health and well-being of our stockholders and other meeting participants. Stockholders will have the same rights and opportunities to participate in the virtual meeting as they would have at an in-person meeting. To gain access to the meeting, stockholders must go to the meeting website at 